NIH Boosts Pharmacogenomics Research with Six New Programs and at Least $123M in Funding Through 08 | GenomeWeb

The US National Institutes of Health has kicked off the year by launching several programs that promise to support research into genotyping, biomarker analysis, association studies, and related fields that are likely to drive development of personalized medicine through the end of the decade.

NIH is contributing at least $123 million towards the new programs, with additional funding from a range of partners in other governmental agencies and private industry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.